These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Retinoids in the prevention of bladder cancer. Nutting CM; Huddart RA Expert Rev Anticancer Ther; 2001 Dec; 1(4):541-5. PubMed ID: 12113086 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point. Decensi A; Torrisi R; Bruno S; Costantini M; Curotto A; Nicolò G; Malcangi B; Baglietto L; Bruttini GP; Gatteschi B; Rondanina G; Varaldo M; Perloff M; Malone WF; Bruzzi P Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1071-8. PubMed ID: 11045790 [TBL] [Abstract][Full Text] [Related]
16. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Kurth KH; Bouffioux C; Sylvester R; van der Meijden AP; Oosterlinck W; Brausi M Eur Urol; 2000; 37 Suppl 3():1-9. PubMed ID: 10828681 [TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach. Schulze M; Stotz N; Rassweiler J J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695 [TBL] [Abstract][Full Text] [Related]
18. An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy. Duque JL; Loughlin KR Urol Clin North Am; 2000 Feb; 27(1):125-35, x. PubMed ID: 10696251 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant intravesicular pharmacotherapy for superficial bladder cancer. Lum BL; Torti FM J Natl Cancer Inst; 1991 May; 83(10):682-94. PubMed ID: 1827165 [TBL] [Abstract][Full Text] [Related]